Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9940658 | American Journal of Hypertension | 2005 | 5 Pages |
Abstract
Based on the study results, ARR and low renin activity may predict the response to spironolactone in never-treated hypertensive patients but not in patients taking antihypertensive drugs, possibly because of the effect of these agents on ARR. In such patients a trial of spironolactone is required to assess the BP response.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Azra Mahmud, Mohammed Mahgoub, Mary Hall, John Feely,